Monoclonal antibody treatment: Why it's so difficult to distribute
October 5, 2021
41,739
216
180
0.95%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Washington Post Episodes Around October 5, 2021
See what was published immediately before and after this episode.
2:45SNL premieres with a new Biden and a Kyrsten Sinema who hates everything
4:28Now PlayingMonoclonal antibody treatment: Why it's so difficult to distribute
YouTube Description
as posted by the channelIn September, the Biden administration moved to stave off shortages of monoclonal antibodies, taking over distribution of the critical covid-19 treatment. Their use has become more widespread in the United States in recent months, especially in the Deep South due to high infection rates.
“These antibodies were found to be remarkably effective if given early, within 10 days of symptoms,” said Upinder Singh, a professor of infectious diseases at Stanford University. “They reduced the risk of hospitalization or death by almost 80 percent. They reduce the symptoms by four days.”
Monoclonal antibody treatments are effective and free to highrisk coronavirus patients, but experts say the treatment alone cannot prevent the next surge of cases. “The vaccine is what you take to prevent disease, what you take so that you don't get sick,” said Singh, adding that antibody treatments are currently only used for patients infected with covid19. “So that's a difference, right, to prevent illness versus treat illness.” Read moreSubscribe to The Washington Post on YouTube
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.